Revenue: The sum of all revenue fields included for a company's operating activities.
Akebia Therapeutics, Inc. (AKBA) had Revenue of $53.54M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$53.54M |
$-9.05M |
|
$12.29M |
|
$41.25M |
|
$58.24M |
|
$-4.70M |
|
$-4.23M |
|
$-8.93M |
|
$-8.93M |
|
$-9.05M |
|
$-9.05M |
|
$-9.05M |
|
$-9.05M |
|
$-4.70M |
|
$-4.37M |
|
267.05M |
|
267.05M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$243.48M |
|
$0.96M |
|
$119.04M |
|
$362.52M |
|
$173.88M |
|
$36.40M |
|
$161.26M |
|
$335.14M |
|
$27.37M |
|
$-31.67M |
|
$27.38M |
|
267.90M |
|
| Cash Flow Statement Financials | |
$-21.21M |
|
$-0.06M |
|
$-0.93M |
|
$186.54M |
|
$164.35M |
|
$-22.20M |
|
$3.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
0.57 |
|
1.79 |
|
77.05% |
|
-8.77% |
|
-8.77% |
|
-- |
|
-16.67% |
|
-16.91% |
|
$-21.27M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.95 |
|
0.86 |
|
105.11 |
|
-33.07% |
|
28.59% |
|
-2.50% |
|
-14.20% |
|
$0.10 |
|
$-0.08 |
|
$-0.08 |
|